Surya Medical Research Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 32 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
- Revenue Growth 49.73%
- Profit Growth 3.50%
- Ebitda -0.03%
- Net Worth 8.83%
- Total Assets 19.70%
About Surya Medical Research Center
Surya Medical Research Center Private Limited (SMRCPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 1993 and has a history of 32 years. Its registered office is in Bathinda, Punjab, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹4.50 M.
Gurjeet Khurana, Inderjit Khurana, and Abhay Khurana serve as directors at the Company.
Company Details
-
Location
Bathinda, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110PB1993PTC012989
-
Company No.
012989
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jan 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Surya Medical Research Center?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurjeet Khurana
|
Director | 27-Jan-1993 | Current |
|
Inderjit Khurana
|
Director | 27-Jan-1993 | Current |
|
Abhay Khurana
|
Director | 03-Jan-2020 | Current |
Financial Performance of Surya Medical Research Center.
Surya Medical Research Center Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.73% increase. The company also saw a slight improvement in profitability, with a 3.5% increase in profit. The company's net worth moved up by a moderate rise of 8.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Medical Research Center?
In 2019, Surya Medical Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Patiala : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2002 | State Bank Of Patiala | ₹4.50 M | Open |
How Many Employees Work at Surya Medical Research Center?
Unlock and access historical data on people associated with Surya Medical Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Medical Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Medical Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.